Speakers and Presenters

See the full list of speakers and presenters below. For the full conference schedule, click the link below.


Outstanding Presentations

These presenters were recognized for their outstanding lectures, flash talks and posters at Psychedemia 2022.

Uma Chatterjee

MDMA-AT, PTSD, & Comorbid OCD: Exploring the potential effects of 3,4-Methyledioxymethamphetamine assisted therapy for PTSD on comorbid OCD.

Rebecca Krisel

Refreshing the Psychedelic Policy Image: A News and Social Media Sentiment Analysis of the Psychedelic Renaissance.

Sarah Gorban

The Microbiome: Psychedelics Beyond the Brain, A Call to Research.

Emily Cribas

A gut feeling: How our intestinal cellular network could bidirectionally shape psychedelics and their therapeutic effects.

Tahlia Harrison

Altered Stakes: identifying gaps in the psychedelic-assisted therapy research informed consent process.

Robert A. Villa

Toad Smoke: (Un)natural History of Incilius alvarius, the Sonoran Desert Toad.

Michael V. Kramer

Notes toward a Phenomenological Philosophy of Psychedelics.

Keynote Speakers

Alicia Danforth bio photo

Alicia Danforth

Characters vs Character: Why Truth and Norming Matter in Psychedelics.

Alicia Danforth, PhD, is a clinical psychologist and psychedelics researcher. She began working in research with psychedelics in 2004 on the pilot study of psilocybin treatment for cancer-related anxiety at the Harbor-UCLA Medical Center. She was an investigator for the pilot study of MDMA-assisted therapy for social anxiety in autistic adults, and she was a lead clinician for the pilot study of psilocybin-assisted group therapy for demoralization in long-term survivors of HIV at UC San Francisco. She currently is bookending her research career with a return to psilocybin in palliative care, with a new emphasis on training. For her “day job,” Alicia runs a private practice in California tailored to the needs and preferences of autistic adults.

James Davies bio photo

James Davies

Dr. James Davies has a PhD from the University of Oxford in social and medical anthropology. He is now a Reader in Social Anthropology and Psychology at the University of Roehampton, London. He has practiced as a psychotherapist in the NHS, England. He is the co-founder of the Council for Evidence-based Psychiatry (CEP), which is secretariat to the All Party Parliamentary Group for Prescribed Drug Dependence (Westminster, London). He has also been an expert drug advisor for the UK government. He is the author of Cracked: the unhappy truth about psychiatry, and the more recent Sedated: why capitalism caused our mental health crisis. He has published academic books with Stanford University Press, Sage, Palgrave Macmillan and Routledge, while is articles have appeared in The Times, The New Scientist, The Guardian, The Daily Mail, Harvard Divinity Bulletin, Therapy Today, Mad in America and Salon. He has spoken widely in the media, and has also extensively consulted for the BBC and ITV., and other media outlets.

William Leonard Pickard bio photo

William Leonard Pickard

Alleged to have produced “90% of the world’s LSD,” William Leonard Pickard is a former drug policy fellow at the Kennedy School of Government at Harvard, research associate at Harvard Medical School, and deputy director of the Drug Policy Analysis Program at UCLA. His 1996 prediction of the fentanyl epidemic, and recommendations for prevention, occurred two decades before the event. The RAND Corporation discussed PIckard’s work in its seminal “The Future of Fentanyl and Other Synthetic Opioids.” Given two life sentences without possibility of parole, Pickard served 20 years in maximum security federal prisons. In 2020, he was granted compassionate release. Presently, Pickard is a senior advisor to the biotechnology venture firm JLS Fund and to the Fireside Project.

Yarelix Estrada

Yarelix Estrada, MSPH, is a first-generation Central American, drug policy and harm reduction researcher, advocate, and community outreach worker. Yarelix works as a City Research Scientist with the New York City Department of Health and Mental Hygiene conducting community-based substance use harm reduction outreach and research. Her work is currently largely focused on implementation of the first higher-technology drug checking research study in New York City with local syringe service programs and overdose prevention centers. Yarelix is passionate about supporting people throughout the full continuum of drug use, from use for pleasure and healing to overdose prevention. She is dedicated to improving the quality of care for people who use drugs and historically oppressed communities by working to understand the intersectionality between health policy and the societal factors that impact the lives of people who use drugs. She is the director of the New York City Psychedelic Society, is on the Board of Directors for the Tennessee Recovery Alliance, the Board of Directors for the Source Research Foundation, on the Advisory Board of the psychedelic media group Psymposia and is an organizer with the Urban Survivors Union and the Alliance for Collaborative Drug Checking. She received her Master of Science in Public Health in Health Policy at the Johns Hopkins Bloomberg School of Public Health.


Lectures are broken up into panels of up to four speakers, each followed by a Q & A with the audience. Panels will take place in the morning, afternoon, and evening of Saturday the 13th as well as in the morning and afternoon of Sunday the 14th.

Adam Levin

Perceptions of Psychoactive Drugs among Psychiatrists in the United States: The Impact of National Drug Policy.

Adam Levin, M.D. is a Resident in the Department of Psychiatry and Behavioral Health at the Ohio State University School of Medicine and an Affiliate Scholar at the Center for Psychedelic Drug Research and Education at the Ohio State University College of Social Work. He received his M.D. from the Louisiana State University School of Medicine where he was elected to the Alpha Omega Alpha Honor Society. While completing his medical degree, he studied the anxiolytic and antidepressant properties of psilocybin and ketamine in animal models of depression in the lab of Charles Nichols, Ph.D. His current research and clinical interests include the therapeutic applications of psychedelic drugs in the treatment of addiction and in Veterans with PTSD, the implications of drug policy for medical education and practice, and the overlap between psychiatry and spirituality. In addition to his clinical responsibilities, he serves as a facilitator for the mindfulness-based stress reduction program, Mindfulness in Motion, which targets individuals in high stress work environments. Dr. Levin has been recognized for both his clinical work and his role in medical student education and was the recipient of the 2021 Arnold P. Gold Humanism and Excellence in Teaching Award.

Alan K. Davis

Psilocybin therapy for people with depression: Clinical trial outcomes and case reports.

Dr. Davis is a Clinical Psychologist and the Director of the Center for Psychedelic Drug Research and Education in the College of Social Work at Ohio State University. He is Assistant Professor of Social Work and Psychiatry at OSU and is also on the faculty in the Department of Psychiatry at Johns Hopkins University. Alan has extensive clinical experience working with US Military Veterans and civilians suffering with addiction, PTSD, and depression. His research explores alternative treatments for addiction and mental illness, including psychedelic-assisted therapies, and how to increase access to current treatment systems through reducing provider stigma about substance misuse and alternative treatment approaches. Alan has published over 70 scientific articles and book chapters and presented research at dozens of national and international scientific conferences. Published landmark trial in 2021 on the use of psilocybin therapy for depression in JAMA psychiatry. In 2022, he is launching a pilot study of the first psilocybin trial for Veterans with PTSD.

Alyssa Gursky

Capturing the Ineffable: Integrating Art Therapy into Psychedelic Therapy.

Alyssa Gursky (she/they) is a psychedelic therapist, art therapist, and psychedelic researcher based out of Portland, Oregon. They are the owner and operator of Psychedelic Art Therapy, a small private practice focused on reconnecting people to their creative power and finding peace in their bodies. Additionally, Alyssa works at Sequoia Center, a burgeoning clinic centered around accessibility to psychedelic therapy and research around Measure 109, the Psilocybin Service Center Program.

Ana Flecha

Choreographing re-membrance: The Santo Daime bailado and epistemologies of dance in the context of psychedelic science.

Ana Flecha is a PhD candidate in the Latin American and Latino Studies Department at the University of California, Santa Cruz. She is researching the epistemological implications and subjectivities of the Santo Daime bailado, a dance central to this ayahuasca religion from Brazil’s southern Amazon region. Since 2010 she has been offering her eco-corporeal practice ReinCORPOra as part of educational programs promoting principles of environmental sustainability in the Northeast of Brazil. Through her research Ana is developing the interdisciplinary concept of corpo/realization, acknowledging self-movement as the source of all knowledge and bringing the field of postmodern dance studies to psychedelic science.

Austin Haigler

Psychedelic Studies: Towards a Nascent Field of Inquiry.

A first generation university student born and raised in the rural South, Austin completed a Bachelors of Arts Degree in Political Science from North Carolina State University in 2012 while a member of the Varsity Men’s Wrestling Team. Completed a Master of Arts in Liberal Studies (MALS) Degree in 2017 with a focus on the history and political economy of the English-speaking university press system. An upcoming PhD student in the Communication, Rhetoric and Digital Media (CRDM) Program at North Carolina State University (Fall 2022) studying the political rhetoric of the War on Drugs, the materiality of the academic monograph, and the integration of psychedelic science into “mainstream” university curriculum.


Brian Pace

From on High: Right-Wing Psychedelia and Mystic Authoritarianism.

Brian Pace, PhD teaches Psychedelic Studies: Neurobiology, Plants, Fungi, and Society in the Department of Plant Pathology at The Ohio State University. He was trained as an evolutionary ecologist, specializing in phytochemistry, ethnobotany, and ecophysiology. He is the Politics and Ecology Editor at Psymposia, a 501c3 watchdog. His research has examined ideology and psychedelic experiences. It has been featured in VICE, translated into French and Italian, and covered internationally. A former US Borlaug Global Food Security Fellow, he has conducted field work in Southern Mexico, the US midwestern prairie, and the Ecuadorian Amazon. For more than a decade, Brian has worked on agroecology and climate change. Along the way, he has taught several university courses on cannabis.

Carli Domenico

LSD alterations of sleep architecture and hippocampal activity during cortical slow wave sleep in resting rat.

Dr. Carli Domenico is a postdoctoral researcher in the Daoyun Ji lab at Baylor College of Medicine where she got her PhD in neuroscience. Her thesis work investigated the effects of the hallucinogen, LSD, on areas in the brain involved in spatial cognition and sensory processes. This work can be found in her 2021 paper in Cell Reports, which she will be incorporating into the discussion today. In the lab, she continues projects investigating LSD and the role of the serotonergic 5HT2A-receptor as well as fear memory extinction through social learning. She has studied sleep, cognition, and sensory systems in various labs- and in systems including rodents, astronauts, and even pigeons. She has been a member of leadership with the Intercollegiate Psychedelics Network for two years now and currently serves as a director in the organization- charged with facilitating progress and development for students in the psychedelic space.

Carsten Fisher

Deep Roots: Unveiling the Impact of Systemic Racism in the Medicalization of Psychedelics with Critical Race Praxis.

Carsten Fisher is a behavioral psychologist by training, experienced in working with populations diagnosed with an array of mental health challenges and passionate harm reduction advocate. Carsten has been a student of psychedelic-assisted healing modalities and integration practice, and his passion is grounded in service of BIPOC and LGBTQIA+ communities, prioritizing accessibility & equity, harm reduction, and disrupting systems of oppression that impact the psychedelic community. In his personal life, Carsten likes to rock climb, study and practice Zen Buddhism, write poetry, and eat yummy food with friends.

Christopher C. Davoli

Lived Experiences with Long-Term Psychedelic Therapy and Healing: What Patients Want Professionals to Know.

Chris is an Associate Professor of Psychology at Central Michigan University. He earned his B.S. in Psychology from Davidson College and his Ph.D. in Psychology from Washington University in St. Louis, and he completed post-doctoral training in visual cognition at the University of Notre Dame. His current teaching and research interests include psychedelics, perception, and embodiment, and he recently led the development of a new undergraduate course, PSY 200E: Psychedelics and Psychology, at CMU. His work on the present project is an attempt to bring the academic and the patient/client tracks of psychedelic therapy together, in hopes that it might help others (and the field) going forward.

Emily K. Bloesch

Beyond Consultation: A Working Group Approach to De-Siloing Psychedelics Studies.

Emily K. Bloesch is an Associate Professor of Psychology at Central Michigan University. She earned her B.S. in Experimental Psychology from Millikin University, M.A. in Applied Experimental Psychology from Western Kentucky University, and Ph.D. in Psychology with a concentration in aging and development from Washington University in St. Louis. Her current teaching and research interests include cognitive aging, psychedelics, attention, and embodiment. Her research team has published works on psychedelics in psychological science include historiographical analyses, systematic reviews, and theory/perspective papers.

Emma Stamm

Acid Communism and Psychedelic Science in the Age of Digital Capitalism.

Emma Stamm is Visiting Assistant Professor of Philosophy at Villanova University. Her research interests are in critical theory, contemporary continental philosophy, and STS. She also publishes cultural criticism and fiction for non-academic publications. Her website is www.o-culus.com.

Graham St. John

Apocalypse Raver: Terence McKenna as Medium.

Graham St John, PhD, is a cultural anthropologist specialising in transformational events, movements and figures. A Marie Curie Senior Research Fellow at the University of Huddersfield and author of the forthcoming intellectual biography Terence McKenna: The Strange Attractor (MIT Press, 2023), among his nine books are Mystery School in Hyperspace: A Cultural History of DMT (North Atlantic Books 2015), Global Tribe: Technology, Spirituality and Psytrance (Equinox 2012), and an anthology of essays he is currently co-editing (with Kevin Whitesides) on McKenna. Graham is Executive Editor of Dancecult: Journal of Electronic Dance Music Culture. His website is: www.edgecentral.net.

Guillermo de Orbegoso

Possible contributions of the Expressive Arts methodology to the reduction of risks associated with the use of psychedelic substances.

Guillermo de Orbegoso is an expressive arts therapist candidate by TAE Peru (Center for the studies of Expressive Arts Therapy) training program. At the moment, he is writing his thesis on the possibilities offered by the Expressive Arts in the reduction of risks associated with the use of psychedelic substances trough the arts based research methodology. The subject of this research arises as a response to his experience with ayahuasca and other plants in a retreat in the Peruvian Amazon, where he studied the Shipibo healing traditions, experience that would call attention of the inherent risks of psychedelic decentering. In this research he also studies the interaction between the expressive arts and other psychoactive substances such as psilocybin mushrooms and DMT. He has worked on the design and application of interdisciplinary workshops for the prevention of domestic violence and violence in schools, as well as psychotherapeutic care in cases of natural disasters and recently in the care of psychological emergencies due to the health crisis.

Hilary Agro

Prohibitionist Realism: Scenes from the front lines of movements against drug prohibition.

Hilary Agro is a PhD candidate in Anthropology at the University of British Columbia. Her ethnographic research focuses on how people whose drug use is criminalized build solidarity and connection while resisting prohibition and its entanglements in structures of racial capitalism. Her work on consciousness alteration in urban North American settings also focuses on the subjective and contextual benefits and pleasures of self-administered drug use in non-medical social settings, which are widely recognized and experienced by users themselves, but seldom included in academic or mainstream discussions of drugs. Hilary has run workshops on psychedelics, harm reduction, destigmatization, and consent culture, and she is passionate about public outreach and abolitionist activism, with a large audience on Twitter and TikTok (@hilaryagro). She received her Master’s in Anthropology from the University of Western Ontario.

Isla Weber

Positive vs. negative context mediates the effects of psilocybin on acute anxiety circuit activation and long-term anxiety‑like behaviors in mice.

Isla Weber is from Bloomington, Indiana and grew up surrounded by art and performance. Isla recently completed her undergrad degree in neuroscience at Princeton University, and completed her senior thesis research on the influence of context on psilocybin’s effect on mice. She is excited to pursue a career in clinical research in the field of psychedelics and will be applying for MD-PhD programs in the coming year. She is the Director of Operations at the Intercollegiate Psychedelics Network, a volunteer, student-run organization dedicated to providing professional development resources and programs to enhance students’ preparedness for careers in the psychedelic field.

J. Christian Greer

Between Stoned Apes & Space Stations: The Psychedelic Militants of the New Age Movement.

J. Christian Greer, PhD, is a scholar of Religious Studies with a special focus on psychedelic culture. His forthcoming book, Angelheaded Hipsters: Psychedelic Militancy in Nineteen Eighties North America (Oxford University Press), analyzes the diversification and expansion of psychedelic culture within fanzine networks in the late Cold War era. He will begin a fellowship at Yale University’s Institute of Sacred Music in 2023, where he will use the Beinecke’s collections to research his second book, which will be the first investigation of its kind into the historical imbrication of psychedelic spirituality and the movement for Civil Rights.

Jacob Green

Hallucinations of the Afterlife during Dental and Surgical Anesthesia as a Challenge to How Mystical Experience is Defined in Psychedelic Therapy.

Jacob is a PhD candidate in the History of Science, Medicine and Technology at UCLA. Broadly, his research focuses on the history of the interaction between psychoactive drugs, psychology, philosophy and religion in the late 19th and early 20th centuries. The goal of his work is to understand how drugs, which today would be called psychedelic, were historically understood in Western culture, academia and spirituality in a time decades before the psychedelic research and drug cultures of the 1950s and 60s. His work has been supported by the Source Research Foundation, The Science History Institute and the American Institute of the History of Pharmacy.

Jason C. Slot

The first trip: origins of psilocybin on Earth.

Dr. Slot is a Fungal Biologist in the Department of Plant Pathology at the Ohio State University and the Director of Educational Initiatives for the CPDRE. Dr. Slot conducts basic research in fungal evolutionary ecology, including the ecology and evolutionary genomics of psychedelic mushrooms. His lab has been central to early discoveries in the genetics of psilocybin production, and continues to explore the genomes of fungi for insights into the ecology of the substances they produce. Dr. Slot teaches courses in mycology and chemical ecology, initiated the interdisciplinary undergraduate Mycology Minor, and contributes an ecological perspective to the core Psychedelic Studies courses at OSU.

José Manuel Rodríguez Arce

Going beyond McKenna’s “stoned ape theory”: testing the Psychedelic Instrumentalization model of human evolution.

José Manuel Rodríguez Arce is an independent researcher based in Costa Rica. Primarily an autodidactic, transdisciplinary inquirer, José holds a BSc in Biology and is currently pursuing a second BSc in Anthropology at the University of Costa Rica (UCR). He was previously research assistant at the Neuropsychopharmacology Laboratory, Faculty of Pharmacy and at the Carlos H. Aguilar Piedra Archaeology Laboratory, School of Anthropology, both at the UCR. His current research focuses on universality and diversity in human psychoactive drug use. He is exploring available ethnographic and behavioral data in order to gain a more accurate view of why humans have a predilection for inebriation and how this preference has evolved in our species. José is the originator of the Psychedelic Instrumentalization model of human evolution, an empirically testable version of Terence McKenna’s so-called “stoned ape theory” that posits psychedelics helped humans both create and respond to an obligatorily cooperative, social-learning-dependent lifestyle—the socio-cognitive niche. He is currently building a database that systematically aggregates and analyzes cross-cultural information on psychedelic drug use in order to test predictions derived from this hypothesis.

Kai River Blevins

Suspending the Self: Psychedelics, Embodiment, and Minimal Subjectivity.

Kai River Blevins (they/xe) is a third-year PhD student in the Anthropology department at George Washington University. Xe studies psychedelic politics in the United States, with a particular focus on how psychedelic experiences inform political and linguistic practices. Kai’s work is public and activist in nature, and they are currently organizing with activists attempting to change the legal status and regulation of psychedelics at the federal level in the United States. Their research explores what happens when consciousness and bodily autonomy become the focus of political and ethical projects, and how that ongoing process shapes (inter)subjectivity, political practice, community building, scientific and therapeutic practice, and state governance. Kai holds a Master in Legal Studies from Willamette University College of Law, and a B.A. in Sociology and Political Science from the University of Colorado-Denver.

Logan Neitzke-Spruill

Embodied Cognition and Psychedelics: Toward a Biocultural Understanding of Set, Setting, and Transformation.

Logan Neitzke-Spruill is a Ph.D. candidate in Sociology at the University of Delaware. His research interests include the sociocultural dimensions of drug experiences, embodied cognition, neuro-ethics, as well as the science, culture, and policy of psychoactive drugs. His dissertation investigates the emergence of the scientific/intellectual movement centered on psychedelics and examines how this movement challenges existing knowledge about drugs and mental health. Additionally, by critically engaging psychedelic research, he explores how psychedelics can advance our understanding of the interrelationship of culture, cognition, and the brain. Logan’s past work focuses on how sociocultural phenomena shape drug experiences. Specifically, his previous research examines social determinants of overdose deaths, as well as how “set and setting” shape the interpretation of psychedelic experiences. His solo and co-authored work has appeared in Sociological Forum, Journal for Studies on Alcohol and Drugs, Journal of Psychedelic Studies, and Journal of Psychoactive Substances.

Marty Otañez

The Transnational Psychedelics Capitalist Class and Its Consequences for Anti-Capitalist Psychedelic Studies.

Marty Otañez, Chair and Associate Professor, Anthropology Department, University of Colorado Denver. My areas of interest are cannabis workers’ health and labor rights, and corporate malfeasance in the global psychedelic sector. Recent publications of include “Cannabis Corporate Social Responsibility Initiatives: A Critical Approach to Research and Practice;” “A Labor Studies Approach to Cannabis,” The Routledge Handbook of Interdisciplinary Cannabis Research (2021); and “Health and Safety in the Legal Cannabis Industry Before and During COVID-19, New Solutions: A Journal of Environmental and Occupational Health Policy (2020). In 2022, I am working on a visual ethnographic project to understand BIPOC and low-income people’s experiences and knowledge about psilocybin use in non-therapeutic spaces in Colorado.

Matthew Baggott

Lessons from San Francisco’s Summer of STP.

Matthew Baggott, PhD, is co-founder and CEO of Tactogen, a public benefit corporation that is developing a next-generation of MDMA-like medicines. Before starting Tactogen, Matthew was most recently a Director of Data Science & Engineering at Genentech. Matthew studied philosophy as an undergraduate at University of Chicago and earned his PhD in neuroscience at University of California Berkeley.

Meghan DellaCrosse

“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.

Meghan DellaCrosse is a doctoral candidate at the Wright Institute in Berkeley, CA, and a pre-doctoral intern at Wexner Medical Center’s EPICENTER / Early Psychosis Research Program in the Department of Psychiatry and Behavioral Health at The Ohio State University. She is contributing to research and manuscript development as a part of the Translational Psychedelic Research (TrPR) Program at UCSF on the Bipolar Psilocybin Project (BiPsi). She previously worked as a clinical assessor on various studies including investigations of social deficits in Veterans with schizophrenia, and psilocybin as a novel treatment for depression and Parkinson’s disease. Meghan is passionate about interdisciplinary research and holds master’s degrees in clinical psychology from Columbia University, Teachers College (NY), and art history from CUNY Hunter College (NY). As a somatic educator and qualified Mindfulness-Based Stress Reduction instructor, Meghan’s research interests focus on novel treatments and the integration of the body into mental health care to support people with serious mental illness, as well as promoting mental health literacy and reducing stigma.

Michael Lifshitz

Cultivating relationships with invisible beings: From tulpas and tryptamines to speaking in tongues.

Michael Lifshitz is an Assistant Professor in the Division of Social and Transcultural Psychiatry at McGill University in Montreal, Canada. He studies practices that aim to transform subjective experience—from meditation and hypnosis to placebos, prayer, and psychedelics. He is particularly interested in how these practices can modulate feelings of agency, so that thoughts, actions, and sensations can come to feel as if they are emerging from a source beyond the self. Michael did his PhD in Neuroscience at McGill and then a postdoctoral fellowship in Anthropology at Stanford. His work combines phenomenology, neuroscience and ethnography to shed light on the plasticity of consciousness.

Michael V. Kramer

Notes toward a Phenomenological Philosophy of Psychedelics.

Michael V. Kramer is a PhD Candidate in philosophy at Duquesne University. He is originally from Los Angeles, received his bachelor’s degree in philosophy from UCLA, and has recently returned from a Fulbright Study stay at the Universität Heidelberg for the 2021-22 Academic Year. He is currently writing his dissertation, in which he analyzes the process of sense-institution within psychedelic experience according to the theoretical framework of Maurice Merleau-Ponty’s phenomenological philosophy.

Neşe Devenot, PhD bio photo

Neşe Devenot

Psychedelic Identity Shift: A Critical Approach to Set and Setting.

Neşe Devenot, PhD (she/they) is a Postdoctoral Associate at the Institute for Research in Sensing (IRiS) at the University of Cincinnati and the Medicine, Society & Culture Research Fellow at Psymposia. She previously completed a postdoctoral fellowship in the Department of Bioethics at the Case Western Reserve University School of Medicine, and she received her PhD in Comparative Literature from the University of Pennsylvania. Her scholarship examines bioethical approaches to psychedelic medicine, and she conducts research on the function of metaphor and other literary devices in narrative accounts of psychedelic experiences. They were awarded “Best Humanities Publication in Psychedelic Studies” from Breaking Convention in 2016 and received the Article Prize for best publication in Romanticism Studies from European Romantic Review in 2020. They were a 2015-16 Research Fellow at the New York Public Library’s Timothy Leary Papers and a Research Fellow with the New York University Psilocybin Cancer Anxiety Study, where they participated in the first qualitative study of patient experiences. They have presented on psychedelics at conferences in the United States, Mexico, Canada, England, France, the Netherlands, and Australia.

Parker Singleton

Psychedelics flatten the brain’s energy landscape: insights from receptor-informed network control theory.

Parker is a PhD candidate and NSF Graduate Research Fellow in Computational Biology at Cornell University. He is studying the effects that potent serotonergic compounds have on brain
activity/connectivity and the development of computational models to drive targeted brain therapies. He hopes his research can be used to inform theories of consciousness and to better understand, diagnose, and treat mental disorders.

Patti Zettler

A Right to Try Psychedelics? Pathways for Treatment Use of Unapproved Psychedelics.

Patti Zettler, JD is an associate professor at The Ohio State University Moritz College of Law and a faculty member of Ohio State’s Drug Enforcement and Policy Center and its Comprehensive Cancer Center. Her research and teaching focus on FDA law and policy, torts, and legislation and regulation. Her scholarship has appeared in leading legal and health sciences journals such as the Food and Drug Law Journal, Indiana Law Journal, the Boston College Law Review, New England Journal of Medicine, JAMA, and Science, and has covered various topics including expanded access, stem cell interventions, opioids, cannabis products, tobacco and nicotine products, and COVID-19 countermeasures. Zettler also is a co-author of the forthcoming 5th edition of Food and Drug Law: Cases and Materials (with Peter Barton Hutt, the late Richard A. Merrill, Lewis A. Grossman, Nathan Cortez, and Erika Lietzan). She currently serves on the Food and Drug Law Institute’s (FDLI) Board of Directors and on the International Society of Cell & Gene Therapy’s (ISCT) Committee on the Ethics of Cell and Gene Therapy. She also chairs ISCT’s working group on expanded access. Previously she served on the National Academies of Sciences, Engineering, and Medicine’s (NASEM) Committee on Reviewing the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE), on FDLI’s Black Lives Matter Advisory Committee, on the International Society for Stem Cell Research’s Task Force to Revise Guidelines, on the Food and Drug Law Journal’s Editorial Advisory Board, and as a consultant to the NASEM Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Before entering academics, Zettler served as an attorney in the Office of the Chief Counsel at FDA. She received her undergraduate and law degrees from Stanford University, both with distinction.

Paul Elias

Critical Reflections on the ‘Psychedelic Renaissance’ and ‘Acid Communism’ from the perspective of Karl Marx’s Social Philosophy.

Paul Elias, PhD, is a contract faculty member in the department of Social Science at York University, Toronto. His academic background encompasses Marx’s social philosophy, German Idealism, ancient Hellenic philosophy, phenomenology, critical theory, and psychoanalysis. His current research focuses on contemporary extreme politics of the far-right, subjectivity, cross-disciplinary psychological theory, and the philosophy of mind. He presented at the first Psychedemia conference in 2012.

Rafaelle Lancelotta

Considerations for Ethical Integration of Psychedelics in Healthcare.

Rafaelle Lancelotta, MS, LPC is a PhD student at The Ohio State University College of Social Work studying the importance of human relationship in psychedelic therapy interventions. They received their Master’s degree in Mental Health Counseling from the University of Wyoming and worked for several years as a somatic-focused, trauma-informed counselor who has supported clients use of cannabis and ketamine to enhance the therapeutic process. They are passionate about increasing accessibility and responsible clinical applications of psychedelics/entheogens for under-represented populations. Rafaelle aims to use their clinical skills combined with doctoral level research training to design, carry out, and integrate clinical research as part of diverse teams to influence changes in the mental healthcare system that can serve to improve mental health outcomes for people from all walks of life. Rafaelle also serves as a Board Member for the Source Research Foundation, a non-profit grant organization geared towards supporting students and communities working on psychedelic-related projects.

Robert A. Villa

Toad Smoke: (Un)natural History of Incilius alvarius, the Sonoran Desert Toad.

Robert A. Villa is a Research Associate at the Desert Laboratory, University of Arizona, and president of Tucson Herpetological Society. He has been a bio-cultural scholar of the Sonoran Desert region from an early age, writing about it, and consulting for media outlets. He has advocated for the conservation of the Sonoran Desert Toad in light of its growing and misguided demand as a source of 5-MeO-DMT.

Shana Harris

Traveling for Treatment: Accessing Psychedelics and Addiction Care in Mexico.

Shana Harris, Ph.D., is an Assistant Professor in the Department of Anthropology and the Department of Internal Medicine (Secondary Joint Appointment) at the University of Central Florida. Her research focuses on drug use, “addiction,” and health politics and interventions, including harm reduction, medications for opioid use disorder, and drug policy reform, in Latin America and the United States. Her current work examines psychedelic-based drug treatment in Mexico and the implementation of harm reduction programs in Florida.

Stacey B. Armstrong

Differences in attitudes and beliefs among social workers, psychiatrists, and psychologists on psychedelic-assisted therapy.

Dr. Armstrong joined The Ohio State University in Spring 2022 as a Post Doctoral Scholar in the College of Social Work. She completed her graduate training at Bowling Green State University, which included an internship at the University of Michigan’s Mary A. Rackham Institute. In 2016, she completed a clinical post-doctoral fellowship at Summa Health’s Traumatic Stress Center in Akron, OH. She is a licensed clinical psychologist specializing in treating trauma and traumatic stress across the lifespan. At OSU, Dr. Armstrong is pursuing the integration of practice and research investigating medication-assisted treatment among individuals with various mental health concerns, including posttraumatic stress disorder (PTSD). In addition to researching novel treatments for PTSD among adults, her research program also includes the impacts of other stressors, like cyber-victimization and problematic media use, among adolescents. Through her research, Dr. Armstrong seeks to promote the psychological wellbeing of individuals across the lifespan who experience a range of stressors, including trauma, and are experiencing distress.

Tahlia Harrison

Altered Stakes: identifying gaps in the psychedelic-assisted therapy research informed consent process.

Tahlia Harrison, MA, MFTA, LMT is a registered marriage and family therapy associate, bioethicist, researcher, and educator born and raised (mostly) in Portland, Oregon. She is from an ethnically, culturally, spiritually, and racially mixed background, a first-generation graduate student, cisgender, and able-bodied. Tahlia holds a masters degree in Marriage, Couple, and Family Therapy from Lewis & Clark’s Graduate School of Counseling, a program centering systemically oriented, culturally responsive, antiracist, clinical training; this approach accounts for the cultural, social, and spiritual issues that shape the whole person. Tahlia is committed to continual work in these areas and understanding how her identities enter the therapy room, the research lab, and the spaces she occupies outside of it. Tahlia recently completed an additional masters degree in Bioethics and Science Policy at Duke University examining topics related to ethics, psychedelic research, and mental health disparities. This fall she will be continuing her research as a Ph.D. candidate in Experimental Psychology and Psychedelic Therapies under Dr. Monnica Williams in her laboratory Culture and Mental Health Disparities at the University of Ottawa.

Trace Reddell

Psychedelic Praxis: Integrating Transformational Experiences in the Liberal Arts Classroom.

Trace Reddell (PhD) is a writer, artist and educator exploring the interactions of sound and the cosmological imagination. Trace’s first book, The Sound of Things to Come: An Audible History of the Science Fiction Film (U of Minnesota Press, 2018), takes a groundbreaking approach to sound in science fiction films that offers new ways of construing both sonic innovation and science fiction cinema. He is also the author of a forthcoming book, The Magic Circle: Sonic Substance in Psychedelic Music (MIT Press, 2023), which develops a new theory of sonic psychedelia. Trace’s audiovisual performances and video projects have been presented at over thirty international venues and new media festivals. Trace is a Professor and Director of the Emergent Digital Practices program at the University of Denver, where he teaches courses in sound studies and sonic arts, expanded cinema, science fiction studies, speculative materialism, psychedelic studies, and spiritual technology design.

Victoria Grace Litman

A Tax Study of Entheogenic Religious Practices in America in 2022: Existing Structures and Future Possibilities (and Problems).

Victoria Litman is an expert at the intersections of drug law, religious freedom law, and tax law. She recently graduated with honors from Georgetown with a Master’s in Tax Law and New York Law School with a JD. Prior to law school, Victoria studied Religion and Archaeology at the University of Southern California and earned a Master of Divinity from Union Theological Seminary, where she concentrated in Religion and Law. As a Graduate Tax Scholar at Georgetown, she conducted research about how tax law impacts entheogenic religious communities which is being presented for the first time at Psychedemia 2022. Her other writing at Georgetown included: “Balancing Religious Freedom with the Government’s Interest in Promoting Public Health: Exploring the Legal Future of Entheogens,” “Joint Ventures Between Tax Exempt Non-Profits and For-Profit Entities in the Emerging Cannabis and Psychedelic Industries,” and “A Study of the Dormant Commerce Clause as Applied to State Tax Laws: Why Cannabis Should Not Be Treated Like Insurance.” Victoria is a founding member of the Psychedelic Bar Association and a member of the Religious Use and Legalization and Regulation Committees. She is currently training to become a certified Ganjier (a cannabis sommelier) and finishing her forthcoming book about Religion, Drugs, and (Tax) Law. She recently joined Parlatore Law Group as counsel where her practice will focus on cannabis, psychedelics, and tax with an emphasis on nonprofits and exempt organizations. Victoria is a longtime medical cannabis patient advocate and Reform Rebbetzin. She resides in Rumford, Rhode Island with her dog Deli and her partner.

Vivek Shah

Trip Anxiety: Heidegger’s Existential Analytic in the Phenomenology of Psychedelics.

Vivek Shah is a Ph.D. student at the Department for the Study of Religion at the University of Toronto. He completed his M.A. in religion at the University of Chicago Divinity School in 2021, and his B.A. in philosophy and religious studies from Rutgers University in 2017. His areas of research and interest are: Sanskrit philosophy, post-comparitive philosophy, German philosophy, ontology, phenomenology, deontic logic, Sanskrit jurisprudence, and political theology. His proposed dissertation discusses spatial ontology in the commentarial works of the Vedānta school in the Sanskrit philosophical tradition. He is also working on a project that applies the phenomenological method toward understanding the Hindu texts known as the Vedas. Hoping originally to pursue psychedelic clinical research after high school, his interests in the philosophy of psychedelics date back to 2012, when he interviewed members of the Johns Hopkins Bayview Medical team headed by Roland Griffoths. Over time, these interests have evolved into a more theoretical consideration of psychedelics in spiritual and philosophical practices.

Yitong Xin

Psychedelic therapy for United States military Veterans: Prospective data from a clinical program in Mexico.

Yitong Xin is a Ph.D. Candidate in the College of Social Work at The Ohio State University (OSU). Her overarching research areas focus on four themes: substance use, harm reduction, trauma, and resilience. Specifically, her research focuses on understanding the complex interactions between the risk factor of trauma and the protective factor of resilience, utilizing a harm-reduction treatment approach (e.g., psychedelic-assisted therapies, non-abstinent treatment goals) for people with substance misuse behaviors and mental health issues. Yitong is a Licensed Social Worker and Eye Movement Desensitization and Reprocessing (EMDR) trained therapist in the state of Ohio. Yitong has practiced as a clinical social worker since 2016 in outpatient mental health settings.

Flash Talks

Flash talks are each 3 minutes in length. Flash talk sessions will take place after the afternoon keynote presentations on Saturday the 13th and Sunday the 14th.

Alexsandra Kovacevich

Cases of reported improvement in anosmia following naturalistic use of classic psychedelics.

Alexsandra Kovacevich, MD is a third year psychiatry resident at the Cleveland Clinic. She currently leads the Cleveland Psychedelic Science Group and previously served as the CCF Chair of Resident Wellness. She trained as a Registered Yoga Teacher before completing her medical education at the University of Toledo. Her primary research interests include the medical use of psychedelics and the relationship between autoimmune pathology and neuropsychiatric symptoms.

Connor J. Storck

Psychedelic Hermeneutics.

Connor J. Storck is a second-year Juris Doctor Candidate at the University of Detroit Mercy School of Law. Connor holds an M.A. in Religion and a graduate certificate in Gnosticism, Esotericism, and Mysticism from Rice University. At Rice, Connor focused on the historical and contemporary study of religious experiences by both American and European psychologists, as well as methods of textual interpretation present throughout the Long Sixties (1954-1975); his Master thesis was entitled, “Psychedelics and Religious Insight: A Precedent in American Psycho-Spirituality from William James to Timothy Leary” (2021). Before Rice, Connor received a B.A. in Religious Studies with minors in Jewish Studies, Asian Studies, and Economics from Michigan State University. Connor has also researched the role of pilgrimage in Italy at John Cabot University, and in Israel at Hebrew University.

Daniel J. Kruger

Assessing Psychedelic Knowledge among Psychedelic Enthusiasts.

Daniel Kruger is a researcher in the Institute for Social Research and Michigan Medicine at the University of Michigan. He applies evolutionary principles to advance the understanding of a wide range of areas in human psychology and behavior, much of this research is founded on Life History Theory. Dr. Kruger conducts both basic research to advance theory as well as applied projects to promote human well-being. He is involved in several community-university research collaborations promoting the understanding of and improving local social and health conditions. About a decade ago, he began a research program on the medicinal use of Cannabis, investigating its naturalistic use and the degree of integration with or disconnection from the mainstream healthcare system. He is now taking a similar approach with the medicinal use of psychedelics, in order to maximize benefits and minimize the costs, risks, and harms to individuals and society.

Dave Rojas

Ketamine and Ketamine Assisted Psychotherapy in a Low-income Ethnically Diverse Sample: A Phenomenological Study.

Dave Rojas holds a B.A. in psychology from San Francisco State University and a M.A. in clinical psychology from Alliant International University – San Francisco Bay Area. He is currently a Ph.D. candidate in clinical psychology at Alliant International University – San Francisco Bay Area and his dissertation is focused on the phenomenological experience of ketamine assisted psychotherapy (KAP) in an ethnoracially and socioeconomically diverse sample of patients. He is a recipient of a 2021 Source Research Foundation (SRF) Source Award, a 2021 SRF BIPOC Award, and a 2022 Usona Institute Scholarship. He will be starting his predoctoral internship at the Federal Medical Center – Rochester, MN in August 2022. His clinical interests include forensic psychology, psychotic disorders, personality disorders, neuropsychology, clinical psychopharmacology, and psychedelics assisted psychotherapy.

Dustin Theibert

From Gilded Cages to Psychedelic Commons: Mending Patents for Open Science.

Dustin is a research scientist at The Ohio State University, where he studies microbiological processes of fungal systems. His focus is on education of mycological understanding through environmental interactions. He previously researched materials science development applications, including novel biopolymer products and associated intellectual property review. Dustin has a MS in Chemistry from Bowling Green State University and is furthering his education with plans to pursue a PhD related to understanding the complex interactions of neurochemistry and the evolution of fungal secondary metabolites.

Jamarie Geller

The Use of Psychedelics in Medicine: Are Future Providers, Allied Professionals, and Researchers Being Educated? A Survey Study.

Jamarie holds a Master’s in contemplative psychotherapy and is currently a third year psychiatry resident at the University of Michigan with plans to pursue fellowship in child and adolescent psychiatry. She has clinical and research interests in the realms of trauma (MAPS trainee), mood disorders, psychotherapy including psychedelic and ketamine-assisted therapies, complementary, alternative, and integrative psychiatry, and mindfulness and medication in medicine. In her abundant free time she enjoys running (just did my first 5K!), crosswords, yoga, pickle ball, and conferences.

JoJo (Joseph) Martis

Selective Attention Differences across Altered States of Consciousness.

As a military child through development, JoJo has moved countless times, as result embedding an intuitive sympathy for diversity and inclusion, motivating his professional development and interests. He recently completed his master’s in Experimental Psychology with a concentration in Cognitive Neuroscience at Texas Tech University. His thesis “Investigating How Individual Differences in Selective Attention Relate to Schizotypy and Altered States of Consciousness” proposes his interests in the implications of attention during psychedelic-related states and how it may illustrate possible routes toward subjective well-being. He is currently a full-time Research Associate for the NeuRO Lab affiliated with OSU Medical Center and a part-time graduate student as he prepares for a Ph.D. program in Fall 2023.

Joshua M. Ellow

Clinical Social Workers and Psychedelic-Assisted Therapies: A Qualitative Study on Knowledge, Attitudes, and Professional Response.

Joshua Ellow is a dedicated father, partner, educator, and animal lover. Dr. Ellow earned his PhD from the Center for Social Work Education at Widener University where he is also an adjunct professor and a trauma track supervisor. Following the successful defense of his dissertation, which focused on social work and psychedelic-assisted therapies, Dr. Ellow was awarded with the Thomas M. Young Outstanding Dissertation Award for rigor, creativity, and serious contribution to the social work profession. Dr. Ellow was also the featured speaker at the 2022 Graduate Research Symposium at Widener University. Dr. Ellow serves a sole role as Swarthmore College’s Alcohol and Other Drug Counselor and Educator where he is also an Assistant Visiting Professor in Swarthmore’s Environmental Studies department. While being certified as an Advanced Drug and Alcohol Counselor and a Co-Occurring Disorder Professional Diplomat, Dr. Ellow provides consultation and trainings to organizations and families. In 2020, Ellow completed a four-year appointment with the NCAA committee on Competitive Safeguards and Medical Aspects of Sport. Within these roles, Dr. Ellow has developed and supported behavioral initiatives on a local and national scale.

Katrina Dobson

Behavioural Investigations of Psilocybin in Animals, A Scoping Review.

Bio coming soon.

Nathan D. Sepeda

The relationship between amygdala response and long-term antidepressant effects after psilocybin therapy.

Nathan Sepeda is the Research Data Specialist and co-facilitator for the Johns Hopkins Center for Psychedelic and Consciousness Research (CPCR) and a Research Assistant at the Center for Psychedelic Drug Research and Education at The Ohio State University. Nathan studied psychology and neuroscience at the University of Minnesota where he had become interested in studying the neural mechanisms underlying mood disorders and substance use disorders. Now, Nathan studies the effects of psychedelic substances and their potential therapeutic effects. He has been involved in several clinical trials with psychedelic substances, including the first randomized control trial investigating the effects of psilocybin in major depressive disorder, and others exploring the effects of psilocybin on brain functioning, cognition, and well-being. In addition to his work with psilocybin, Nathan has also studied the effects of 5-MeO-DMT, ibogaine, salvinorin-A, and ketamine.

Nicolas Glynos

Naturalistic Psychedelic Use: A World Apart From Clinical Care.

Nick Glynos received a botany degree from Cornell University and is now a PhD candidate at the University of Michigan in Ann Arbor in the department of Molecular & Integrative Physiology. His work is mainly focused on the psychedelic compound N,N-Dimethyltryptamine (DMT) including the physiological functions and biosynthesis of endogenous DMT, as well as the neurophysiological and neurochemical correlates of intravenously administered DMT in rats. In addition, he has contributed to several population studies and survey-based projects to better understand how naturalistic psychedelic use interacts with health and wellness, and the integration of psychedelics with conventional healthcare. He is a co-founder of the Psychedelic Neuroscience & Therapy group at Michigan, and is the Vice President of the Student Association for Psychedelic Studies.

Rebecca Krisel

Refreshing the Psychedelic Policy Image: A News and Social Media Sentiment Analysis of the Psychedelic Renaissance.

Rebecca Krisel is a doctoral candidate in political science at the CUNY Graduate Center, where her research centers around movements focused on taboo social issues, policy discourses, and the making of public policy. Her research is wide-ranging, including a study of the influence of the #MeToo movement on making dance spaces safer for women and LGBTQ communities in NYC. She has also studied how LGBTQ youth used digital spaces to create virtual dance parties during the height of the pandemic as a way to cope with social alienation. Finally, her dissertation focuses on the efforts to decriminalize, medicalize, and/or legalize psychedelic substances in the US.

Ronit Kishon

Our science needs to be dosed.

Ronit Kishon, Ph.D., is an Associate Professor of Medical Clinical Psychology in Psychiatry at the New York State Psychiatric Institute(NYSPI), Columbia University. She received her MSc and Ph.D. in clinical psychology at Teachers College, Columbia University, and did her internship at the West-Haven VA, Yale school of medicine. As an expert in treating trauma and depression, she has treated patients with PTSD, depression, and bipolar disorder, including Holocaust survivors, Vietnam War veterans, combat veterans,
and 9/11 survivors and families. Dr. Kishon has overseen the clinical arm of multiple NIMH-funded projects, providing individualized interventions to people with PTSD, anxiety, and depression. She is interested in psychological and neurobiological mechanisms that may shape disease processes and affect
change during psychotherapy; more specifically, she studies changes in emotion processing and self-reflection abilities during CBT for depression. She is currently a principal investigator in an NIMH grant which reflects her interest. She is also a co-investigator in the Global Psychiatric Epidemiology Group, researching children of first responders. In addition, Dr. Kishon directs an
externship program at NYSPI for students in clinical psychology and provides training on trauma-related issues to mental health and primary care providers under Columbia University HIV Mental Health Training Project.

Sarah Gorban

The Microbiome: Psychedelics Beyond the Brain, A Call to Research.

Sarah Gorban is a PharmD candidate at the University of North Carolina Eshelman School of Pharmacy. She received her undergraduate degree in neuroscience at Trinity University in San Antonio, Texas. Her interest in psychedelics is largely centered around the pharmacology and neuroscience components. She is also interested in exploring the potential intersection of psychedelics and the enteric nervous system. Sarah will be pursuing a career in psychedelics, with intentions of becoming a professor, a clinical researcher and a guide. She is also a poet and is exploring creative ways to integrate poetry and psychedelics and has had several psychedelic-themed poems published.

Poster Presentations

Posters will be displayed for the duration of the conference with a dedicated poster session in the evening of Saturday the 13th. Appetizers and bar service will be available during the poster session.

Brian Barnett

Is psychedelic use associated with cancer?: Interrogating a half-century old claim using contemporary population-level data.

Brian Barnett, MD is an Assistant Professor of Psychiatry and Co-Director of the treatment-resistant mood disorders clinic at Cleveland Clinic. Dr. Barnett completed his psychiatry residency at Massachusetts General Hospital and McLean Hospital in 2017. Afterwards, he completed a fellowship in addiction psychiatry at Partners Healthcare in Boston, Massachusetts in 2018 and a fellowship in forensic psychiatry at University Hospitals/Case Western Reserve University in Cleveland, Ohio in 2019. Dr. Barnett’s primary research interests are in catatonia, mood disorders, and medical/non-medical uses of psychedelics. Dr. Barnett also writes about mental health and addiction issues for the public, and his writing has been featured in Vice, the Wall Street Journal, the Washington Post, and other outlets.

Colin Domnauer

Early Investigations into Unstudied Psychoactive Bolete Mushrooms.

Colin Domnauer completed his undergraduate studies at UC Berkeley, where he graduated in 2020 with a bachelor’s degree in Planetary Science. He is now a first-year PhD student studying Mycology at the University of Utah.

David Horton

A Systematized Review of the Psychotherapeutic Components of Psilocybin-Assisted Therapy.

David Horton is a research manager at the University of Wisconsin-Madison, where he contributes to the design and execution of several clinical trials of psilocybin and MDMA for various substance use and related mental health conditions. He has received a Master of Science degree in Clinical Rehabilitation and Mental Health Counseling at the University of North Carolina at Chapel Hill. He defended his Master’s Thesis on the psychotherapeutic components of psilocybin-assisted therapy, which was later accepted for publication in a peer-reviewed journal. David is also a provisionally licensed clinical mental health counselor and certified rehabilitation counselor, with experience in clinical mental health counseling and diagnostic interviewing.

Elyse Smith

Psychedelic drug policy reform: A bioethical principlist approach.

Elyse Smith is a first-year PhD student in medical and environmental anthropology at the University of Connecticut. She holds an M.A in Bioethics & Medical Humanities with a concentration in Medicine, Society, and Culture, and studied psychology and music as an undergraduate. Her early research explored the psychopharmacology, phenomenology, and ethnobotany surrounding ayahuasca, peyote, and iboga, along with their Indigenous contexts, and their contemporary Western applications. Elyse recently collaborated on an interdisciplinary qualitative analysis of participant narrative accounts from Johns Hopkins University’s clinical investigation into psilocybin-assisted psychotherapy for tobacco addiction. Her ongoing scholarship examines environmental ethics & human health, the bioethics of psychedelic medicine, and evidence-based approaches to drug policy–grounded in a decolonial, trauma-informed, human rights perspective. Her forthcoming research will explore psychedelic community integration & harm reduction-based socialized care frameworks, which may diverge from the burgeoning clinical model of psychedelic medicine access and regulation. A cornerstone of this project also seeks to socio-historically contextualize the current ecological and biocultural crisis around peyote regulation by examining tensions between such issues as cognitive liberty and Indigenous sovereignty, and ethnographically highlighting what certain Indigenous epistemologies can tell us about potentially decolonizing sacred plant conservation and drug policy.

Emily Cribas

A gut feeling: How our intestinal cellular network could bidirectionally shape psychedelics and their therapeutic effects.

Emily Cribas is a Ph.D. candidate at the University of Pennsylvania. Her doctoral thesis focuses on the therapeutic role of intestinal repair and cell death processes in stem cells during toxin-mediated damage by C. difficile, an opportunistic pathogen that causes disease exclusively after perturbations to the gut microbiota. Her research primarily employs mouse models of disease and 3D organoids. Her research interest in psychedelics was inspired by her engagement in the Intercollegiate Psychedelics Network (IPN) and a years-long fascination with indigenous dietary practices, also evident in Ayahuasca ceremonies. Her poster builds on a collaborative manuscript on novel therapeutic applications of psychedelics currently in preparation. Finally, she is also a first-generation, low-income Honduran American which has critically informed her perspectives on access, inclusion, and science communication as it relates to her field.

Eric Dobson

Ketamine-assisted Psychotherapy for Persistent Depression in Abstinent Opioid Users: Preliminary Data from an Open Label Trial.

Dr. Dobson is an addiction psychiatry fellow at Medical University of South Carolina. He was born and raised in Cincinnati. He studied biochemistry at The Ohio State University before returning to the University of Cincinnati College of Medicine where he earned his medical degree in 2018. Dr. Dobson then moved to Charleston, South Carolina where he served as chief resident before completing his psychiatry residency in 2022. His research interests include psychedelic-assisted psychotherapy for the treatment of addiction and other treatment-resistant conditions.

Jeffrey Allen Breau

Spiritual Experiences to Spiritual Lives: Models for Ethical, Life-giving Psychedelic Ministry.

Jeffrey Allen Breau is a second-year Master of Divinity candidate at Harvard Divinity School studying Psychedelic Chaplaincy, Hindu philosophy, and end-of-life care. Jeffrey has been involved in the psychedelic community since 2012, has been a longtime volunteer with the Zendo project, and recently moderated a panel at Chacruna’s Religion and Psychedelics Forum titled: “The Dark Night of the Soul: Exploring Bad Trips.” Before Harvard, Jeffrey spent two years overseeing the Taos Ashram founded by Ram Dass, which was dedicated to feeding people, community service, and living a spiritual life after transformative, spiritual experiences. Prior to that, Jeffrey spent six years as a Google project manager, including leading an experimental Diversity and Inclusion project aimed at cultivating empathy. He will be doing street ministry this summer and Clinical Pastoral Education next academic year and aspires to work in Psychedelic Chaplaincy after graduating from HDS.

Natalie Villeneuve

Ways forward in the wake of controversies.

Natalie Villeneuve is a clinical therapist specializing in trauma and sexual abuse prevention through her work with adolescents who have sexually offended. Currently based out of Toronto, Canada, Natalie assesses and treats youth who have experienced physical, sexual, and emotional abuse, as well as youth who have engaged in sexually abusive behaviours. Natalie completed her Masters of Social Work (MSW) at McGill University, where her research focused on understanding treatment needs for Indigenous youth who have sexually offended. Natalie has delivered numerous presentations on working with youth who sexually offend, and she is interested in understanding how Indigenous wisdom can be blended with Western science to enhance current healing practices and offer more wholistic approaches to treating trauma. She is interested in the role that psychedelics can bring to trauma therapy, and her current work focuses on how the psychedelic movement can progress in a way that is safe, ethical, decolonized, and free from sexual abuse.

Russell Hausfeld

From Mining to Mushrooms: Why Are Extractive Industry Executives Speculating On Psychedelics?

Russell Hausfeld is an investigative journalist and illustrator living in Cincinnati, Ohio. He has been covering developments in the psychedelic space for the last five years with Psymposia, and holds a Bachelor’s degree in Journalism and Religious Studies from the University of Cincinnati. His work with Psymposia has been cited in Vice, The Nation, Frontiers in Psychology, New York Magazine’s “Cover Story: Power Trip” podcast, the Daily Beast, the Outlaw Report, Harm Reduction Journal, and more.

Stephanie Schmitz

An Introduction to the Psychoactive Substances Research Collection at the Purdue University Archives.

Stephanie Schmitz is the Betsy Gordon Archivist for the Psychoactive Substances Research Collection. This collecting area brings together primary source materials that document the therapeutic application of psychedelic substances prior to 1960s, as well as the re-emergence of this research area in the 1990s. Her responsibilities include identifying possible acquisitions; educating donors about the Archives role in caring for their materials; promoting the collection and ensuring its visibility; working closely with course instructors in incorporating collection materials for use in curricular activities; and assisting others in utilizing these materials for their research endeavors.

Tara Rodriquez

Use of psychedelic harm reduction strategies among native Spanish-speakers.

Tara Rodriquez is an MSW student in the College of Social Work at The Ohio State University. Her area of emphasis is substance use and mental health, and she is completing her fieldwork internship at NEST Harm Reduction in Los Angeles. She has over three years of harm reduction and psychedelic leadership experience in national and local organizations, including the Psychedelic Society of Los Angeles (PSOLA), which she founded in 2020.

Thomas Daniel Meyer

Exploring the motivation of individuals with Bipolar Disorder for recreational psychedelic use and its effects.

Thomas Daniel Meyer is a Professor of Psychiatry and Behavioral Sciences at the University of Texas Health Science Center at Houston. He is also the Director of the Psychological Intervention and Research Program for Mood Spectrum Disorders (PIRP-M) and Co-Director of the UTHealth Brain Collection. His work encompasses a wide range of areas but he is especially interested in improving outcome and quality of life of individuals experiencing mood disorders, including depression, and their family and informal caregivers. He was the PI of the first and so far only German Randomized Controlled Trial (RCT) of Cognitive Behavior Therapy for Bipolar Disorder (BD), and has since been in involved in several ongoing RCTs looking at family intervention for adolescents with BD (FAB study) or early intervention for BD. His expertise in psychosocial interventions for mood disorders resulted in being nominated originally and for the update as the chair of the taskforce ‘psychoeducation and psychotherapy’ of the national German S3 guideline for assessment and treatment of BD. His taskforce consisted of a multidisciplinary team, patients and their relatives generating the evidence-based recommendations first published in 2013 and recently updated in 2019. His knowledge and expertise was acknowledged in the UK as well as where he was invited as an expert member both to the IAPT Competency Framework for Severe Mental Illness and to the Guideline Development Group for the update of the BD treatment guideline NICE in 2014.

Uma Chatterjee

MDMA-AT, PTSD, & Comorbid OCD: Exploring the potential effects of 3,4-Methyledioxymethamphetamine assisted therapy for PTSD on comorbid OCD.

Uma R. Chatterjee, B.S., MHPS is a neuroscience M.S. student and graduate student researcher, working in the Kolber Lab as part of the Center for Advanced Pain Studies at the University of Texas at Dallas. In the Kolber Lab, Uma is currently studying the cellular and molecular mechanisms of amygdalar neuropeptides and the lateralization of the amygdala’s role in comorbid chronic pain and psychiatric conditions such as posttraumatic stress disorder, obsessive-compulsive disorder, depression, and anxiety disorders. Uma is also a board-certified mental health peer specialist, serving cancer survivors through her MHPS practice and as the founder and facilitator of her global mental health peer support group, the Cancer Thriver Collective. Her survivorship and journey of recovery of cancer, chronic illness, and mental illness serves as the bedrock of her advocacy, carried out through her work as an educator, public speaker, writer, and legislative advocate. Uma most recently had the honor of delivering the keynote address of CancerCon 2022. Uma’s interdisciplinary background and lived experiences all inform her perspective as an emerging researcher in the field of psychedelic neurobiology. Uma is currently conducting an independent systematic review project on the effects of MDMA-assisted therapy for PTSD on comorbid OCD. Her presentation of this idea has won her first place at the PsychedelX 2022 conference, as well as poster presentations at the International OCD Foundation 2022 Research Symposium and the Psychedemia 2022 conference and an accepted manuscript abstract for an upcoming journal on psychedelic science. Uma strives to continue her graduate education and research in neurobiology to further elucidate the underlying mechanisms of obsessive-compulsive disorder, post-traumatic stress disorder, their comorbid nature, and further probing the therapeutic mechanistic underpinnings of psychedelics in relation to these disorders to lessen unnecessary human suffering.

Victor Pablo Acero

A Neurobiological Framework for Psychedelics as Neurotrauma Therapeutics.

Victor Pablo Acero is a PhD candidate in Bioengineering at the University of Pennsylvania. He is a member of the Cullen Lab, which is part of the UPenn’s Center for Brain Injury and Repair (CBIR), as well as the Center for Neurotrauma, Neuroregeneration, and Repair (CNNR). Her doctoral thesis focuses on the development of tissue engineered multi-cellular hippocampal-cortical neural networks for pharmacological investigations, and he plans to utilize this testbed to assess astrocyte-mediated effects of psychedelics on neuronal network function. He also hopes to support preclinical investigations into the therapeutic potential of psychedelics for neurotrauma. His poster builds on a collaborative manuscript on novel therapeutic applications of psychedelics, and significance of preclinical research models for advancing this research (in preparation). He is also co-founder of the Intercollegiate Psychedelics Network (IPN), a student-led non-profit organization developing students into the next generation of leaders in the psychedelic ecosystem. He also serves as Co-chair of the Psychedelic Center Initiative at Penn, which is developing a center focused on transdisciplinary research, student training, and community engagement.

William Campo

Psychedelic Use and Psychological Flexibility: The Role of Decentering and Meaningful Intention.

William Campo was inspired to study psychedelic substances not only through his personal ayahuasca experiences in ceremonial settings and other experiences with psilocybin and LSD, but also through his uncle, who is a visionary shamanic UV artist. For his Master’s thesis, William conducted research with Dr. Yali exploring associations between the psychedelic experience and characteristics such as decentering, mystical experiences, ego-dissolution, insight, and psychological flexibility. That data forms the basis of the current presentation. He is interested in the connection between the psychedelic mystical experience and positive health outcomes such as substance abuse and depression treatments.